Literature DB >> 922761

5-fluorouracil versus CCNU in the treatment of metastatic prostatic cancer.

F Tejada, M A Eisenberger, L A Broder, M H Cohen, R Simon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 922761

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  3 in total

1.  Etoposide, epirubicin and carboplatin in hormone-refractory prostate cancer.

Authors:  H Fuse; Y Muraishi; Y Fujishiro; T Katayama
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

2.  Effect of O6-benzylguanine on the response to 1,3-bis(2-chloroethyl)-1-nitrosourea in the Dunning R3327G model of prostatic cancer.

Authors:  M E Dolan; A E Pegg; N D Biser; R C Moschel; H F English
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

Review 3.  Non-hormonal systemic therapy in men with hormone-refractory prostate cancer and metastases: a systematic review from the Cancer Care Ontario Program in Evidence-based Care's Genitourinary Cancer Disease Site Group.

Authors:  Eric Winquist; Tricia Waldron; Scott Berry; D Scott Ernst; Sébastien Hotte; Himu Lukka
Journal:  BMC Cancer       Date:  2006-05-02       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.